Tricard MR 35 mg is a modified-release anti-anginal medication containing Trimetazidine Dihydrochloride 35 mg. It is used as an adjunctive therapy for the symptomatic treatment of stable angina pectoris in adults who are inadequately controlled by or intolerant to first-line anti-anginal therapies